Grace Therapeutics, Inc. (GRCE) bonds
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.81+0.00 (0.00%)
Close on Nov 13, 2026Market cap $38.08MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Grace Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Grace Therapeutics's 10-K for the period ended Mar 31, 2019
| Issue | Amount issued | Carrying value |
|---|---|---|
| Unsecured Convertible Debentures Convertible | $2.00M | $1.36M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?